© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 08, 2018
EpiFinder, a mobile health application, predicted either an epilepsy syndrome or alternative diagnosis with 86.8% accuracy.
May 02, 2018
Genentech's global head of Neuroscience clinical development detailed the company's commitment to treating the progressive form of multiple sclerosis.
April 29, 2018
Montes' team found benefits in motor function, walking ability, and fatigue in patients to undergo nusinersen (Spinraza) for spinal muscular atrophy.
The Global Head of Neurodegeneration for Genentech talks about the progress of 2 promising monoclonal antibodies.
April 28, 2018
The vice president of Development Sciences for Biogen shared developments to come of the international MS PATHS collaboration.
April 27, 2018
Children receiving AVXS-101 have shown such improvement that researchers are calling for an update to the CHOP-INTEND scale used to track their progress.
April 26, 2018
Patients from 2 demographically-different studies switching from interferon therapy to Aubagio reported similar improvements.
April 25, 2018
The executive vice president and chief medical officer of Biogen explained how crucial it is for potential DMTs to attacki the alpha-synuclein protein.
The director of the Sports Neurology Program at Norton Healthcare and head of the NCAA Headache Task Force discussed trends in his popularizing field.
April 24, 2018
Patients who had previously failed ≥2 preventative migraine treatments were effectively treated with galcanezumab, especially when compared to placebo.